ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000246090.2	ABT-263 (navitoclax)	Breast invasive carcinoma	0.041473354	Resistant
ENSG00000246090.2	ABT-263 (navitoclax)	Colon adenocarcinoma	0.011949574	Sensitive